Abstract
Chronic lymphocytic leukemia (CLL) is an indolent B-cell non-Hodgkin's lymphoma that may transform into higher-grade lymphoma. The transformation involves an increased number of prolymphocytic cells, termed prolymphocytic transformation (PLT) or the development of diffuse large B-cell lymphoma (DLBL), also referred to as Richter's transformation (RT). To analyze whether activation-induced cytidine deaminase (AID), which is essential for somatic hypermutation (SHM) of normal B-cells, and malfunction of SHM termed aberrant somatic hypermutation (ASHM) are associated with higher-grade transformation of CLL, AID mRNA expression and the mutation pattern of c-MYC, PAX-5 and RhoH genes were analyzed in eight cases of CLL without transformation and in 21 cases that showed RT or PLT. Chronic lymphocytic leukemia cases, which showed no transformation or eventually transformed into higher-grade lymphoma, showed low levels of AID mRNA expression and low frequency of mutations of c-MYC, PAX-5 and RhoH genes. In both RT and PLT, high-levels of AID mRNA expression and high-frequency mutations of c-MYC, PAX-5 and RhoH genes were detected. These results indicate that AID expression and ASHM are associated with higher-grade transformation of CLL and provide further evidences that AID expression and ASHM may be activated during the clonal history of B-cell lymphomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Richter M . Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 1928; 68: 368–373.
Foucar K, Rydell RE . Richter's syndrome in chronic lymphocytic leukemia. Cancer 1980; 46: 118–134.
Jaffe ES, Harris NL, Stein H, Vardiman JW . Pathology and genetics of tumours of haemopoetic and lymphoid tissues. In: Banks PM, Warnke RA (eds). World Health Organization Classification of Tumours. IARC Press: Lyon, 2001.
Tsimberidou AM, Keating MJ . Richter syndrome. Cancer 2005; 103: 216–228.
Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Küppers R et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341–346.
Gaidano G, Pasqualucci L, Capello D, Berra E, Deambrogi C, Rossi D et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 2003; 102: 1833–1841.
Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler OD, Deckert M . Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 2004; 103: 1869–1875.
Bödör CS, Bognár Á, Reiniger L, Szepesi Á, Tóth E, Kopper L et al. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma. Br J Haematol 2005; 129: 373–376.
Libra M, Capello D, Gloghini A, Laura P, Berra E, Cerri M et al. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection. J Pathol 2005; 206: 87–91.
Kuppers R, Klein U, Hansmann ML, Rajewski K . Cellular origin of human B-cell lymphomas. N Engl J Med 1999; 341: 1520–1529.
Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA editing deaminase family in germinal center B cells. J Biol Chem 1999; 274: 18470–18476.
Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T . Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553–563.
Okazaki I, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003; 197: 1173–1181.
Kuppers R, Goossens T, Klein U . The role of somatic hypermutation in the generation of deletions and duplications in human Ig V region genes and chromosomal translocations. Curr Top Microbiol Immunol 1999; 246: 193–198.
Csernus B, Timár B, Fülöp Z, Bognár A, Szepesi A, László T et al. Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cell origin of mediastinal B-cell lymphoma. Leuk Lymphoma 2004; 45: 2105–2110.
Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.
Albesiano E, Messmer BT, Damle RN, Allen SL, Rai KR, Chiorazzi N . Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood 2003; 102: 3333–3339.
Cerutti A, Zan H, Kim EC, Shah S, Schattner EJ, Schaffer A et al. Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells. J Immunol 2002; 169: 6594–6603.
Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, van Noesel CJ . Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 2003; 63: 3894–3898.
Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003; 101: 3574–3580.
Oppezzo P, Dumas G, Lalanne AI, Payelle-Brogard B, Magnac C, Pritsch O et al. Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells. Blood 2005; 105: 2495–2503.
Guikema JE, Rosati S, Akkermans K, Bende RJ, van Noesel CJ, van Krieken JH et al. Quantitative RT-PCR analysis of activation-induced cytidine deaminase expression in tissue samples from mantle cell lymphoma and B-cell chronic lymphocytic leukemia patients. Blood 2005; 105: 2997–2998; discussion 2998–2999.
Lossos IS, Levy R, Alizadeh AA . AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia 2004; 18: 1775–1779.
Timar B, Fulop Z, Csernus B, Angster C, Bognar A, Szepesi A et al. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. Leukemia 2004; 18: 326–330.
Nilsen H, An Q, Lindahl T . Mutation frequencies and AID activation state in B-cell lymphomas from Ung-deficient mice. Oncogene 2005; 24: 3063–3066.
Oppezzo P, Vuillier F, Vasconcelos Y, Dumas G, Magnac C, Payelle-Brogard B et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood 2003; 101: 4029–4032.
Acknowledgements
This work was supported by grants from the Hungarian Ministry of Health ETT 144/2003 and 147/2003, and from the Hungarian Scientific Research Foundation OTKA T032572, T034410 and TS49887.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reiniger, L., Bödör, C., Bognár, Á. et al. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia 20, 1089–1095 (2006). https://doi.org/10.1038/sj.leu.2404183
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404183
Keywords
This article is cited by
-
Loss of AID exacerbates the malignant progression of CLL
Leukemia (2022)
-
Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
Scientific Reports (2020)
-
Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia
Annals of Hematology (2019)
-
Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies
Annals of Hematology (2018)
-
Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells
Scientific Reports (2017)